Valuation (7%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -11.39 | 37.05 |
PEG Ratio (TTM) | -1.38 | -2.99 |
P/S Ratio (TTM) | 4.24 | 6.28 |
P/B Ratio (TTM) | 32.58 | 4.59 |
P/FCF Ratio (TTM) | -19.32 | 45.67 |
Price to 5YR AVG Earnings Ratio | N/A | 63.25 |
Price to 5YR AVG FCF Ratio | N/A | 35.41 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -29.17% | 5.47% |
ROE (TTM) | -205.41% | 25.57% |
Net Profit Margin (TTM) | -36.74% | 2.92% |
ROIC 5YR AVG | N/A | 4.71% |
Growth (27%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 6.10% | -10.24% | N/A |
Revenue | 6.47% | 7.28% | N/A |
Net Income | 3.47% | -11.43% | N/A |
Cash Flow | -16.62% | -16.70% | N/A |
Health (37%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 5.59 | 2.48 |
Quick Ratio (TTM) | 4.77 | 1.86 |
D/E Ratio (TTM) | 6.22 | 0.01 |
Interest Coverage (TTM) | -2.61 | 12.18 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 6.91 |
LTL to 5YR AVG FCF | N/A | 3.65 |
Shares Outstanding Growth 5YR AVG | N/A | 2.13% |